Definitive Healthcare Corp.

Technology
Computer Software: Prepackaged Software
www.definitivehc.com

Moat Score
Safety Score

Market Cap $312.62M
PE -1
Debt $257.81M
Cash $105.38M
EV $465.05M
FCF $45.85M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$591.45M
EBIT	-$633.75M
ROE	-97%
ROA	-58%
FCF	$45.85M
Equity	$607.19M
Growth Stability	1
PE	-0.53
PB	0.51
P/FCF	6.82
P/S	1.24
Price/Cash	0.34
Debt/Equity	0.42
Debt/FCF	5.62
Net Margins	-235%
Gross Margins	78%
Op. Margins	-251%
Sales Growth YoY	-6%
Sales Growth QoQ	-1%
Sales CAGR	25%
FCF CAGR	20%
Equity CAGR	6%
Earnings Growth YoY	534%
Earnings Growth QoQ	-55%

Sales CAGR 5Y	25%
FCF CAGR 5Y	23%
Equity CAGR 5Y	-7%
Earnings CAGR 3Y	13%
Sales CAGR 3Y	13%
FCF CAGR 3Y	27%
Equity CAGR 3Y	-27%
Market Cap	$312.62M
Revenue	$252.20M
Assets	$1.09B
Total Debt	$257.81M
Cash	$105.38M
Shares Outstanding	116.64M
EV	465.05M
Moat Score	1%
Safety Score	84%
Working Capital	209.01M
Current Ratio	2.3
Gross Profit	$197.47M
Shares Growth 3y	8%
Equity Growth QoQ	-13%
Equity Growth YoY	-49%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Definitive Healthcare Corp is a leading provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution. Geographically, it derives a majority of revenue from the United States.

SEC Filings

Direct access to Definitive Healthcare Corp. (DH) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Definitive Healthcare Corp. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Definitive Healthcare Corp. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Definitive Healthcare Corp. Discounted Cash Flow

Fully customizable DCF calculator online for Definitive Healthcare Corp..

Years

Calculation mode

= $1.9B

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$46M	$55M	$66M	$79M	$95M	$114M	$137M	$165M	$198M	$237M	$285M	$2.9B
DCF		$50M	$55M	$60M	$65M	$71M	$77M	$85M	$92M	$101M	$110M	$1.1B
Value	$1.9B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2020	12/2021	12/2022	12/2023	12/2024	TTM
Net Margins	-43%	-37%	-10%	-115%	-235%	-235%
ROA	-1%	-1%	-2%	-17%	-58%	-58%
ROE	-4%	-4%	-1%	-24%	-97%	-97%

Bad Net Margins (-234.51%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2020	12/2021	12/2022	12/2023	12/2024	TTM
Debt over FCF	21.88	15.16	10.09	7.11	5.62	5.62
Debt over Equity	0.4	0.19	0.18	0.23	0.42	0.42
Growth Stability	-	-	-	-	-	1

Bad Debt/FCF ratio (5.62)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Good Debt/Equity ratio (0.42)

The company is not overleveraged and has a good balance between equity and debt.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2020	12/2021	12/2022	12/2023	12/2024	CAGR 5Y
Revenue YoY growth	-	40%	34%	13%	0%	25%
Earnings YoY growth	-	20%	-64%	1K%	104%	-
Equity YoY growth	-	26%	-1%	-19%	-49%	-7%
FCF YoY growth	-	-15%	47%	40%	20%	23%